Various studies showed that PMK2 expression’s impediment by shRNA elevates the sensitivity of tumor cells to treatment with docetaxel, and that cells with silenced PKM2 were more prone to undergo apoptosis [88,190,191]. The gene discussed is PKM; the disease is neoplasm.